General Information
Version
6.5
Revision date
2023-10-27
Product name
1-Chlorooctadecane
CAS No.
3386-33-2
Emergency telephone
+81 (3)4531-1145, +81 (0)3 4520 9637
Icons in SDS
Company Information
company name
Merck Ltd.
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H413
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Warning Warning
Hazard statements
H315 Causes skin irritation. H413 May cause long lasting harmful effects to aquatic life. Reduced Labeling (<= 125 ml) H413 May cause long lasting harmful effects to aquatic life.
Precautionary statements
P264 Wash skin thoroughly after handling. P273 Avoid release to the environment. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water. P332 + P313 If skin irritation occurs: Get medical advice/ attention. P362 + P364 Take off contaminated clothing and wash it before reuse. none
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Skin irritation (Category 2), H315 Long-term (chronic) aquatic hazard (Category 4), H413 For the full text of the H-Statements mentioned in this Section, see Section 16.